Gina Guinasso's Colleagues at CivicaScript
Gina Guinasso's Contact Details
United States
CivicaScript
Gina Guinasso's Company Details
WHY CIVICASCRIPT? Because while many generic medicines cost less than brand name drugs, some high-cost generics are more expensive than they need to be due to lack of competition in the market. With generic medicines accounting for nearly 90 percent of all prescriptions, medication costs can dictate whether patients fill or ration their generic prescriptions. CivicaScript is intent on addressing that problem. WHO CIVICASCRIPT SERVES CivicaScript works to deliver these medicines to U.S. patients at a fraction of their current cost, saving consumers hundreds of millions of dollars annually within a few years post launch. The first CivicaScript generic medicines will be available to individuals and families across the country as early as 2022 through retail and mail-order pharmacies. THE BACK STORY "Not long after Civica's hospital-based model was showing promise, another Civica entity was formed in partnership with the Blue Cross Blue Shield (BCBS) Association and multiple independent BCBS companies…CivicaScript focuses on producing generic retail and outpatient drugs…In like fashion to Civica, CivicaScript has grown rapidly; its partners already represent close to 100 million lives and the entity is just getting started." – From "The Health Care Utility Model: A Novel Approach to Doing Business" NEJM Catalyst | Innovations in Care Delivery, July 2021In summary: CivicaScript is the new Civica operating unit dedicated to lowering the cost of select high-cost generic medicines at the pharmacy counter. Using a cost-plus and price transparent model, CivicaScript, with its founding members including Blue Cross Blue Shield Association (BCBSA) and 18 Independent BCBS health plans, Anthem and others, will transform prescription drug distribution to lower the cost of prescription medicines and ensure that consumers benefit from these medicines at a fraction of their current cost.